Tomomichi Iizuka
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Aging modulates amyloid clearance kinetics during anti-amyloid therapy: evidence from real-world serial amyloid PET.
Journal: Frontiers in aging neuroscience
Published: February 01, 2026
Smiling difficulties in Alzheimer's disease linked to reduced nucleus accumbens and pallidum brain volume: Deep learning insights.
Journal: Artificial intelligence in medicine
Published: January 05, 2025
Improvements in dementia classification for brain SPECT volumes using vision transformer and the Brodmann areas.
Journal: International journal of computer assisted radiology and surgery
Published: October 04, 2024
Investigation of a model for evaluating cognitive decline from facial photographs using AI.
Journal: Geriatrics & gerontology international
Published: September 07, 2023
Screening of Alzheimer's disease by facial complexion using artificial intelligence.
Journal: Aging
Published: November 03, 2020
Spatial metabolic profiles to discriminate dementia with Lewy bodies from Alzheimer disease.
Journal: Journal of neurology
Published: January 06, 2020
The Limitation of Evaluating Cingulate Island Sign by SPECTAuthors' Reply.
Journal: Journal of neuropathology and experimental neurology
Published: December 05, 2019
Validity of the posterior limbic circuitry hypothesis as a basis for the cingulate island sign.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: January 23, 2019
Deep-learning-based imaging-classification identified cingulate island sign in dementia with Lewy bodies.
Journal: Scientific reports
Published: January 04, 2019
Cingulate island sign temporally changes in dementia with Lewy bodies.
Journal: Scientific reports
Published: June 28, 2017
Metabolic correlate of memory-deficit awareness in dementia with Lewy bodies: Implication in cortical midline structure.
Journal: Psychiatry research. Neuroimaging
Published: February 24, 2017
Preventive Effect of Rifampicin on Alzheimer Disease Needs at Least 450 mg Daily for 1 Year: An FDG-PET Follow-Up Study.
Journal: Dementia and geriatric cognitive disorders extra
Published: February 20, 2017
Last Updated: 09/26/2026